After-hours 17:40 (ET)VKTX Latest Quarter’s Earnings
Announce Date10/28/2026
EPS Actual (USD)-1.55
Revenue Actual (USD)0.00
Viking Therapeutics Inc Earnings Dates & Reports
This page offers detailed Viking Therapeutics Inc earnings data including the latest Viking Therapeutics Inc earnings report, the upcoming Viking Therapeutics Inc earnings date, historical data and Viking Therapeutics Inc earnings call news.
VKTX Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
VKTX FY2025 Earnings
EPS (YoY)-3.19-216.52%
Revenue (YoY)0.00--
Viking Therapeutics Inc (VKTX) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 10/28/2026 | 09/2026 | -1.55/-1.07 | 0.00/0.00 | -45.65% | -- |
| 7/29/2026 | 06/2026 | -1.10/-1.25 | 0.00/0.00 | 11.70% | -- |
| 4/29/2026 | 03/2026 | -1.37/-1.01 | 0.00/0.00 | -35.11% | -- |
| 2/11/2026 | 12/2025 | -1.38/-0.89 | 0.00/0.00 | -54.65% | -- |
| 10/22/2025 | 09/2025 | -0.81/-0.68 | 0.00/0.00 | -19.30% | -- |
| 7/23/2025 | 06/2025 | -0.58/-0.45 | 0.00/0.00 | -30.97% | -- |
| 4/23/2025 | 03/2025 | -0.41/-0.32 | 0.00/0.00 | -25.51% | -- |
| 2/5/2025 | 12/2024 | -0.32/-0.28 | 0.00/0.00 | -15.26% | -- |
Viking Therapeutics Inc Latest Earnings Call Transcripts
Viking Therapeutics Q3 2026 Earnings Call: VK2735 Advances, Cash Hits $960M
Viking Therapeutics Q3 2026 earnings call: VK2735 Phase III trials advanced, maintenance data remained positive, and cash reached $960 million.